Lifecore Biomedical Inc

Lifecore Biomedical Inc

LFCR

Get informed when a big investor buys or sells

+ Follow
Market Cap$187.92M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Lifecore Biomedical IncLifecore Biomedical Inc-5.4--167%1.610
$6.25

Target Price by Analysts

32.1% upsideLifecore Biomedical Target Price DetailsTarget Price
$8.68

Current Fair Value

83.5% upside

Undervalued by 83.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$187.92 Million
Enterprise Value$331.03 Million
Dividend Yield$- (-)
Earnings per Share$-0.92
Beta1.06
Outstanding Shares33,261,127

Return

Return on Equity-167.50%ROE
Return on Assets-11.75%
Return on Invested Capital5.25%

Valuation & Multiples

P/E Ratio-5.45P/E Ratio
PEG4.29PEG
Price to Sales1.58Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue2.67
Enterprise Value to EBIT30.33
Enterprise Value to Net Income-13
Total Debt to Enterprise0.48
Debt to Equity9.96Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$-0.29
Average shareholder expectation
Revenue Estimate
$33.13 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 2, 2026
EPS Estimate
$-0.29
Average shareholder expectation
Revenue Estimate
$25.96 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 77.99%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %8.95% 58.06%
Total Invested$17.50M 84.42%
Investors Holding33 75.00%

ESG Score

No data

About Lifecore Biomedical Inc

796 employees
CEO: Albert Bolles

Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the foo...